• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Australian company receives U.S. patent for EpiLASIK procedure

Article

The U.S. Patent Office granted Norwood EyeCare a patent for the EpiLASIK procedure.

The U.S. Patent Office granted Norwood EyeCare a patent for the EpiLASIK procedure. The patent relates specifically to separating the epithelium layer from the surface of the cornea for the purpose of preparing the cornea for laser vision-correction surgery.

According to Norwood, EpiLASIK will progressively become a replacement for LASIK, because EpiLASIK does not require a stromal cut.

Related Videos
Neda Nikpoor, MD, talks about the Light Adjustable Lens at ASCRS 2024
© 2024 MJH Life Sciences

All rights reserved.